Role of MIB1 in predicting survival in patients with glioblastomas

Journal of Neuro-Oncology

Volumn 76, Issue 2, 2006, Pages 193-200

  Maskowitz, Shaye I ^a   Jin, Tao ^a   Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Glioblastomas; MIB1; Predictor; Radiotherapy; Staining; Survival

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 31144449690     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-5262-1     Document Type: Article

References (49)

1. PC Burger SB Green 1987 Patient age, histologic features, and length of survival in patients with glioblastoma multiforme Cancer 59 1617-1625 1:STN:280:BiiC2MbhslI%3D 3030531
2. WJ Curran Jr CB Scott J Horton JS Nelson AS Weinstein AJ Fischbach CH Chang M Rotman SO Asbell RE Krisch 1993 Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 704-710 8478956
3. GE Keles B Anderson MS Berger 1999 The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere Surg Neurol 52 371-379 1:STN:280:DC%2BD3c%2Fit1Oluw%3D%3D 10555843
4. M Lacroix D Abi-Said DR Fourney ZL Gokaslan W Shi F DeMonte FF Lang IE McCutcheon SJ Hassenbusch E Holland K Hess C Michael D Miller R Sawaya 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival J Neurosurg 95 190-198 1:STN:280:DC%2BD38%2FlsFGitA%3D%3D 11780887
5. DC Brown KC Gatter 2002 Ki67 protein: The immaculate deception? Histopathology 40 2-11 10.1046/j.1365-2559.2002.01343.x 1:STN:280:DC%2BD387ntVSltQ%3D%3D 11903593
6. M Colleoni D Zarieh RD Gelber G Viale A Luini P Veronesi M Intra V Galimberti G Renne A Goldhirsch 2003 Preoperative systemic treatment: prediction of responsiveness Breast 12 538-542 10.1016/ S0960-9776(03)00163-2 1:STN:280:DC%2BD3srnvV2nug%3D%3D 14659132
7. FG Barker MD Prados SM Chang RL Davis PH Gutin KR Lamborn DA Larson MW McDermott PK Sneed CB Wilson 1996 Bromodeoxyuridine labeling index in glioblastoma multiforme: Relation to radiation response, age, and survival Int J Radiat Oncol Biol Phys 34 803-808 10.1016/ 0360-3016(95)02027-6 1:CAS:528:DyaK28XisVCitrs%3D 8598356
8. JW Bookwalter III RG Selker L Schiffer M Randall D Iannuzzi M Kristofik 1986 Brain-tumor cell kinetics correlated with survival J Neurosurg 65 795-798 3772478
9. C Bouvier-Labit O Chinot C Ochi D Gambarelli H Dufour D Figarella-Branger 1998 Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas Neuropathol Appl Neurobiol 24 381-388 10.1046/j.1365-2990.1998.00137.x 1:CAS:528:DyaK1cXnsFSgt74%3D 9821169
10. MA Kern KD Feisel M Friese RI Ernestus R Schroder 2003 Proliferative activity of microvascular cells in glioblastomas does not correlate with time to recurrence J Neurooncol 63 9-13 10.1023/A:1023795417525 12814249
11. A Korshunov A Golanov R Sycheva 2002 Immunohistochemical markers for prognosis of cerebral glioblastomas J Neurooncol 58 217-236 12187957
12. H Kuriyama KR Lamborn JR O'Fallon N Iturria T Sebo PL Schaefer BW Scheithauer JC Buckner N Kuriyama RB Jenkins MA Israel 2002 Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas Neuro-Oncology 4 179-186 12084348
13. NS Litofsky TC Mix SP Baker LD Recht TW Smith 1998 Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: No prognostic significance Surg Neurol 50 579-585 1:STN:280:DyaK1M%2Fos1eltQ%3D%3D 9870820
14. C Mawrin S Diete T Treuheit S Kropf CK Vorwerk C Boltze E Kirches R Firsching K Dietzmann 2003 Prognostic relevance of MAPK expression in glioblastoma multiforme Int J Oncol 23 641-648 1:CAS:528:DC%2BD3sXntVCjsLc%3D 12888899
15. KL Chandler MD Prados M Malec CB Wilson 1993 Long-term survival in patients with glioblastoma multiforme Neurosurgery 32 716-720 1:STN:280:ByyB287kvVA%3D 8388081
16. JM Cunningham DW Kimmel BW Scheithauer JR O'Fallon PJ Novotny RB Jenkins 1997 Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value J Neurosurg 86 121-130 1:STN:280:ByiC2c7osVQ%3D 8988090
17. S Enestrom L Vavruch B Franlund B Nordenskjold 1998 Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas Neuro-chirurgie 44 25-30 1:STN:280:DyaK1cvivFyksw%3D%3D 9757314
18. F Kayaselcuk S Zorludemir D Gumurduhu H Zeren T Erman 2002 PCNA and Ki-67 in central nervous system tumors: Correlation with the histological type and grade J Neurooncol 57 115-121 12125971
19. R Kirla E Salminen S Huhtala J Nuutinen L Talve H Haapasalo H Kalim 2000 Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labeling in high grade astrocytomas treated with radiotherapy J Neurooncol 46 71-80 10.1023/A:1006473320474 1:STN:280:DC%2BD3M%2FhtlaltA%3D%3D 10896207
20. L Mastronardi A Guiducci F Puzzilli A Ruggeri 1999 Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen J Neurosurg Sci 43 263-270 1:STN:280:DC%2BD3cvlvFaitw%3D%3D 10864388
21. TJ Montine JJ Vandersteenhoven A Aguzzi OB Boyko RK Dodge BJ Kerns PC Burger 1994 Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms Neurosurgery 34 674-678 1:STN:280:ByuB2sjjtFQ%3D 8008166
22. C Rodriguez-Pereira JM Suarez-Penaranda M Vazquez-Salvado MJ Sobrido M Abraldes F Barros J Forteza 2000 Value of MIB-1 labeling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study J Neurosurg Sci 44 203-209 1:STN:280:DC%2BD3MvntlWjsA%3D%3D 11327289
23. PK Sallinen SL Sallinen PT Helen IS Rantala E Rautiainen HJ Helin H Kalimo HK Haapasalo 2000 Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes Neuropathol Appl Neurobiol 26 319-331 10.1046/j.1365-2990.2000.00240.x 1:STN:280:DC%2BD3cvjvFCntw%3D%3D 10931365
24. SH Torp 2002 Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies Clin Neuropathol 21 252-257 1:STN:280:DC%2BD38jis12msg%3D%3D 12489673
25. A Tortosa N Vinolas S Villa E Verger JM Gil M Brell L Caral T Pujol JJ Acebes T Ribalta I Ferrer F Graus 2003 Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas Cancer 97 1063-1071 10.1002/cncr.11120 12569607
26. H Wakimoto M Aoyagi T Nakayama G Nagashima S Yamamoto M Tamaki K Hirakawa 1996 Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77 373-380 10.1002/ (SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y 1:STN:280:BymB38zjslI%3D 8625247
27. DM Ho CY Hsu LT Ting H Chiang 2003 MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma Am J Clin Pathol 119 715-722 1:CAS:528:DC%2BD3sXjslynsbk%3D 12760291
28. JF Reavey-Cantwell RI Haroun M Zahurak RE Clatterbuck RJ Parker R Mehta JP Fruehauf H Brem 2001 The prognostic value of tumor markers in patients with glioblastoma multiforme: Analysis of 32 patients and review of the literature J Neurooncol 55 195-204 10.1023/A:1013845004294 1:STN:280:DC%2BD387isFGhsg%3D%3D 11859975
29. R Schroder KD Feisel RI Ernestus 2002 Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas J Neurooncol 56 127-132 11995813
30. J Vaquero M Zurita C Morales S Oya S Coca 2000 Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma J Neurooncol 46 11-16 10.1023/A:1006347919565 1:STN:280:DC%2BD3M%2Fhtlalsg%3D%3D 10896201
31. ER Laws IF Parney W Huang F Anderson AM Morris A Asher KO Lillehei M Bernstein H Brem A Sloan MS Berger S Chang 2003 Glioma Outcomes Investigators: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project J Neurosurg 99 467-473 12959431
32. G Bauman K Lote D Larson L Stalpers C Leighton B Fisher W Wara D MacDonald L Stitt JG Cairncross 1999 Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis Int J Radiat Oncol Biol Phys. 45 923-929 1:STN:280:DC%2BD3c%2FjsF2ktQ%3D%3D 10571199
33. DS Mohan JH Suh JL Phan PA Kupelian BH Cohen GH Barnett 1998 Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution Int J Radiat Oncol Biol Phys 42 981-987 10.1016/S0360-3016(98)00296-X 1:STN:280:DyaK1M%2FosVGltg%3D%3D 9869219
34. FG Barker SM Chang PH Gutin MK Malec MW McDermott MD Prados CB Wilson 1998 Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 709-720 9574634
35. M Bredel M Piribauer C Marosi P Birner B Gatterbauer I Fischer T Strobel K Rossler H Budka JA Hainfellner 2002 High expression of DNA topoisomerase IIP and Ki-67 antigen is associated with prolonged survival in glioblastoma patients Eur J Cancer 38 1343-1347 1:CAS:528:DC%2BD38XkslKiur0%3D 12091064
36. FK Albert M Forsting K Sartor HP Adams S Kunze 1994 Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis Neurosurgery 34 45-61 1:STN:280:ByuC28npslQ%3D 8121569
37. JB Fiveash SA Spencer 2003 Role of radiation therapy and radiosurgery in glioblastoma multiforme Cancer J 9 222-229 12952307
38. LA Stewart 2002 Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011-1018 1:CAS:528:DC%2BD38XisV2htro%3D 11937180
39. JN Scott NB Rewcastle PM Brasher D Fulton JA MacKinnon M Hamilton JG Cairncross P Forsyth 1999 Which glioblastoma multiforme patient will become a long-term survivor? A population-based study Ann Neurol 46 183-188 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7 1:STN:280:DyaK1MzntFCrsQ%3D%3D 10443883
40. M Nozaki M Tada H Kobayashi CL Zhang Y Sawamura H Abe N Ishii EG Meir Van 1999 Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression Neuro-Oncology 1 124-137 1:STN:280:DC%2BD3MrgtFCrsw%3D%3D 11550308
41. WC Broaddus Y Liu LL Steele GT Gillies PS Lin WG Loudon K Valerie RK Schmidt-Ullrich HL Fillmore 1999 Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction J Neurosurg 91 997-1004 1:CAS:528:DyaK1MXotV2hsb0%3D 10584846
42. HK Shu MM Kim P Chen F Furman CM Julin MA Israel 1998 The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression PNAS 95 14453-14458 10.1073/ pnas.95.24.14453 1:CAS:528:DyaK1cXns1Glsb8%3D 9826721
43. R Stupp WP Mason MJ Bent van den M Weller B Fisher MJB Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Eng J Med 35 987-996
44. MC Schmidt S Antweiler N Urban W Mueller A Kuklik B Meyer-Puttlitz OD Wiestler DN Louis R Fimmers A Deimling von 2002 Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 321-328 1:CAS:528:DC%2BD38XjtFSltbg%3D 11939587
45. KS Hung SL Howng 2003 Prognostic significance of annexin VII expression in glioblastomas multiforme in humans J Neurosurg 99 886-892 14609169
46. N Shinojima M Kochi J Hamada H Nakamura S Yano K Makino H Tsuiki K Tada J Kuratsu Y Ishimaru Y Ushio 2004 The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme J Neurosurg 101 219-226 15309911
47. IF Pollack RL Hamilton J Burnham EJ Holmes SD Finkelstein R Sposto AJ Yates JM Boyett JL Finlay 2002 Impact of proliferation index on outcome in childhood malignant gliomas: Results in a multi-institutional cohort Neurosurgery 50 1238-1244 12015841
48. CH Rickert R Strater P Kaatsch H Wassmann H Jurgens B Dockhorn-Dworniczak W Paulus 2001 Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases Am J Pathol 158 1525-1532 1:STN:280:DC%2BD3M3gvFKnsw%3D%3D 11290570
49. C Hagel SH Park MJ Puchner D Stavrou 2004 CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas J Neurooncol 66 139-146 10.1023/ B:NEON.0000013496.58236.f0 15015779